Chelsea Ellen Scheithauer Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: M407 State Highway 97, Marshfield, WI 54449 Phone: 715-318-0047 |
Adam Eric Gould, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 506 W 5th St, Marshfield, WI 54449 Phone: 715-897-5231 |
Sheila Marie Johnson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1905 S Central Ave, Marshfield, WI 54449 Phone: 715-898-1665 Fax: 715-898-1240 |
Stephanie Anne Hall Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2001 S Central Ave Ste A, Marshfield, WI 54449 Phone: 608-515-4717 |
Olivia Batien Decleene Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 725 S Central Ave, Marshfield, WI 54449 Phone: 715-387-2729 |
Mr. Michael L Gaziano, MSW LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 252 S Central Ave, Suite 21, Marshfield, WI 54449 Phone: 715-384-7579 Fax: 715-384-8131 |
Anne La Chapelle, CSW, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 725 S Central Ave, Marshfield, WI 54449 Phone: 715-387-2729 Fax: 715-387-4526 |
News Archive
When compared with intensive drug therapy, percutaneous coronary intervention (PCI, angioplasty) was more beneficial in reducing the long-term risk of major cardiac events among heart attack survivors with "silent ischemia", according to a study in the May 9 issue of Journal of the American Medical Association.
Health policy experts hold different views on Saturday's House overhaul vote. Kaiser Health News collected some of their responses.
Researchers at the University of Copenhagen's Department of Nutrition, Exercise and Sports have demonstrated that physical activity prompts a clean-up of muscles as the protein Ubiquitin tags onto worn-out proteins, causing them to be degraded.
Psyadon Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) to study ecopipam in patients with Lesch-Nyhan Disease (LND). The first center at which the drug will be evaluated is Emory University under the direction of Dr. Hyder A. Jinnah, MD, PhD. The study is designed to evaluate the safety and tolerability of different doses of ecopipam in adults (group 1), adolescents (group 2) and children (group 3) with LND.
The death toll from three of the UK's most common cancers has dropped to its lowest level for almost 40 years* - according to new figures released by Cancer Research UK.
› Verified 6 days ago